Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Accepts healthy volunteers

Immunization With BCG Vaccine to Prevent Tuberculosis Infection

ClinicalTrials.gov ID: NCT04453293

Public ClinicalTrials.gov record NCT04453293. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Proof-of Concept, Randomized, Controlled Study of Tuberculosis Immunization With BCG to Prevent Infection in Healthy Adults (TIPI Trial)

Study identification

NCT ID
NCT04453293
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Other
Enrollment
16 participants

Conditions and interventions

Interventions

  • BCG (Tokyo 172) vaccine Biological
  • Placebo Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2021
Primary completion
Jan 15, 2026
Completion
Jan 15, 2026
Last update posted
Jan 22, 2026

2021 – 2026

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Yale University School of Medicine New Haven Connecticut 06510
MedStar Washington Hospital Center/MedStar Health Research Institute Washington D.C. District of Columbia 20010
Hope Clinic of the Emory University Vaccine Center, Emory University Decatur Georgia 30030
Johns Hopkins Bloomberg School of Public Health, Department of International Health, Center for Immunization Research Baltimore Maryland 21205
The Brigham and Women's Hospital Center for Clinical Investigation Boston Massachusetts 02115
Baylor College of Medicine Houston Texas 77030
University of Utah School of Medicine Salt Lake City Utah 84108

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04453293, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04453293 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →